Literature DB >> 33377100

Michaelis-Menten Kinetics Measurements of Aldo-Keto Reductases for Various Substrates in Murine Tissue.

Jakob Morgenstern1, Elisabeth Kliemank1, Marta Campos Campos1, Peter Nawroth1,2, Thomas Fleming1,2.   

Abstract

Aldo-keto reductases (AKRs) are responsible for the detoxification of harmful aldehydes. Due to the large number of isotypes, the physiological relevance of AKRs cannot be obtained using mRNA or protein quantification, but only through the use of enzymatic assays to demonstrate functionality. Here, we present a fast and simple protocol to determine the important Michaelis-Menten kinetics of AKRs, which includes various aldehyde substrates of interest such as 4-hydroxynonenal, methylglyoxal, and malondialdehyde. For complete details on the use and execution of this protocol, please refer to Morgenstern et al. (2017) and Schumacher et al. (2018).
© 2020 The Author(s).

Entities:  

Keywords:  Metabolism; Molecular Biology

Mesh:

Substances:

Year:  2020        PMID: 33377100      PMCID: PMC7757668          DOI: 10.1016/j.xpro.2020.100206

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


  4 in total

1.  Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase.

Authors:  David L Vander Jagt; Lucy A Hunsaker
Journal:  Chem Biol Interact       Date:  2003-02-01       Impact factor: 5.192

2.  Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells.

Authors:  Jakob Morgenstern; Thomas Fleming; Dagmar Schumacher; Volker Eckstein; Marc Freichel; Stephan Herzig; Peter Nawroth
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

Review 3.  Aldo-keto reductase (AKR) superfamily: genomics and annotation.

Authors:  Rebekka D Mindnich; Trevor M Penning
Journal:  Hum Genomics       Date:  2009-07       Impact factor: 4.639

4.  Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes.

Authors:  Dagmar Schumacher; Jakob Morgenstern; Yoko Oguchi; Nadine Volk; Stefan Kopf; Jan Benedikt Groener; Peter Paul Nawroth; Thomas Fleming; Marc Freichel
Journal:  Mol Metab       Date:  2018-09-19       Impact factor: 7.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.